BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34414195)

  • 21. POPDC3 is a potential biomarker for prognosis and radioresistance in patients with head and neck squamous cell carcinoma.
    He X; Xu H; Zhao W; Zhan M; Li Y; Liu H; Tan L; Lu L
    Oncol Lett; 2019 Nov; 18(5):5468-5480. PubMed ID: 31612055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 9 mRNAs-based diagnostic signature for rheumatoid arthritis by integrating bioinformatic analysis and machine-learning.
    Liu J; Chen N
    J Orthop Surg Res; 2021 Jan; 16(1):44. PubMed ID: 33430905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Exploration of omics mechanism and drug prediction of coronavirus-induced heart failure based on clinical bioinformatics].
    Chen XM; Cao F; Zhang HM; Chen HR; Zhang JD; Zhi P; Li ZY; Wang YX; Lu XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):587-592. PubMed ID: 32228827
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis.
    Cheng C; Hua J; Tan J; Qian W; Zhang L; Hou X
    Exp Ther Med; 2019 Jul; 18(1):278-288. PubMed ID: 31258663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
    Mo W; Ding Y; Zhao S; Zou D; Ding X
    PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
    Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
    J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.
    Yang HJ; Xue JM; Li J; Wan LH; Zhu YX
    Mol Genet Genomic Med; 2020 Jun; 8(6):e1200. PubMed ID: 32181600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of potential biomarkers in cervical cancer with combined public mRNA and miRNA expression microarray data analysis.
    Wang S; Chen X
    Oncol Lett; 2018 Oct; 16(4):5200-5208. PubMed ID: 30250588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and validation of the role of matrix metalloproteinase-1 in cervical cancer.
    Tian R; Li X; Gao Y; Li Y; Yang P; Wang K
    Int J Oncol; 2018 Apr; 52(4):1198-1208. PubMed ID: 29436615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated analysis reveals down-regulation of SPARCL1 is correlated with cervical cancer development and progression.
    Wu DM; Shi J; Liu T; Deng SH; Han R; Xu Y
    Cancer Biomark; 2018 Feb; 21(2):355-365. PubMed ID: 29103025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
    Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
    Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated analysis of HPV-mediated immune alterations in cervical cancer.
    Chen L; Luan S; Xia B; Liu Y; Gao Y; Yu H; Mu Q; Zhang P; Zhang W; Zhang S; Wei G; Yang M; Li K
    Gynecol Oncol; 2018 May; 149(2):248-255. PubMed ID: 29572030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 35. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma.
    Zhang H; Zou J; Yin Y; Zhang B; Hu Y; Wang J; Mu H
    PeerJ; 2019; 7():e8096. PubMed ID: 31788359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Key Genes in Association with Progression and Prognosis in Cervical Squamous Cell Carcinoma.
    Meng H; Liu J; Qiu J; Nie S; Jiang Y; Wan Y; Cheng W
    DNA Cell Biol; 2020 May; 39(5):848-863. PubMed ID: 32202912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and Validation of Potential Biomarkers and Their Functions in Acute Kidney Injury.
    Chen J; Chen Y; Olivero A; Chen X
    Front Genet; 2020; 11():411. PubMed ID: 32528518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Critical Genes and Signaling Pathways in Human Monocytes Following High-Intensity Exercise.
    Li P; Luo L
    Healthcare (Basel); 2021 May; 9(6):. PubMed ID: 34067297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-Cell RNA Sequencing Reveals Multiple Pathways and the Tumor Microenvironment Could Lead to Chemotherapy Resistance in Cervical Cancer.
    Gu M; He T; Yuan Y; Duan S; Li X; Shen C
    Front Oncol; 2021; 11():753386. PubMed ID: 34900703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.